Benzinga | Nov 5, 2020 05:01PM EST

Accelerate Diagnostics Q3 EPS $(0.33), Inline, Sales $3.60M Beat $3.27M Estimate

Accelerate Diagnostics (NASDAQ:AXDX) reported quarterly losses of $(0.33) per share which met the analyst consensus estimate. This is a 10.81 percent increase over losses of $(0.37) per share from the same period last year. The company reported quarterly sales of $3.60 million which beat the analyst consensus estimate of $3.27 million by 10.09 percent. This is a 58.52 percent increase over sales of $2.27 million the same period last year.